This article is more than 5 years old. Information may no longer be current.
Amedica and K2M enter distribution agreement
Click Here to Manage Email Alerts
Amedica Corporation has entered into a distribution agreement with K2M to provide surgeons and hospitals in Europe with access to Amedica’s Silicon Nitride interbody spinal fusion devices.
According to a company press release, Amedica and K2M conducted a successful pilot program in select markets in Europe where surgeons were provided the opportunity to integrate Silicon Nitride interbody devices into their offerings for patients with disorders requiring spinal fusion. This pilot program demonstrated a need in these strategic markets for spinal fusion devices devised from a different biomaterial.
“We are thrilled to make Amedica’s Silicon Nitride interbody spinal fusion devices part of our comprehensive international product portfolio,” Eric Major, president and chief executive officer of K2M, stated.